Oncimmune Holdings plc announced that Dr Cheung To ("CT") has stepped down as a non-executive Director of the Company, effective from 19 January 2021. Dr To remains a Director of Genostics Company Limited ("Genostics"), part of the Gene Group Holdings Limited ("GGH") group, and stepping down is expected to enable Dr To focus on the continued development of GGH as it prepares for its future corporate and commercial activities. Genostics remains a significant shareholder of Oncimmune and its recent disposal of shares in Oncimmune, bringing its holding to below 10%, was undertaken in line with GGH's preparation for its anticipated corporate activities. Genostics remains Oncimmune's exclusive partner in China and continues to work closely with Oncimmune to gain market entry.